Article Information
History
- November 8, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- William Cross1,
- Iben Lyskjær1,2,
- Tom Lesluyes4,
- Steven Hargreaves1,
- Anna-Christina Strobl3,
- Christopher Davies1,3,
- Sara Waise4,5,
- Shadi Hames1,
- Dahmane Oukrif1,
- Hongtao Ye3,
- Fernanda Amary3,
- Roberto Tirabosco3,
- Toby Baker4,
- David Barnes6,
- Christopher Steele1,
- Ludmil Alexandrov7,
- Gareth Bond6,
- Genomics England Research Consortium8,+,
- Paul Cool9,10,
- Nischalan Pillay1,
- Peter Van Loo4,$,* and
- Adrienne M Flanagan1,3,$,*
- 1Research Department of Pathology, University College London, UCL Cancer Institute, London, UK
- 2Medical Genomics Research Group, University College London, UCL Cancer Institute, London, UK
- 3Department of Histopathology, Royal National Orthopaedic Hospital, Stanmore, UK
- 4The Francis Crick Institute, London, UK
- 5Cancer Sciences Unit, University of Southampton, Southampton, UK
- 6Institute of Cancer and Genomic Sciences, Birmingham University, UK
- 7University of California, San Diego, US
- 8Genomics England Limited, London, UK
- 9Robert Jones & Agnes Hunt Orthopaedic Hospital NHS Foundation Trust, Oswestry, UK
- 10Keele University, Keele, UK
- ↵*Correspondence to Adrienne M Flanagan, a.flanagan{at}ucl.ac.uk and Peter Van Loo, Peter.VanLoo{at}crick.ac.uk
↵$ contributed equally
Posted November 08, 2021.
A Genetic Model for Central Chondrosarcoma Evolution Correlates with Patient Outcome
